Trial
NCT02137096
Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
—
Condition
Recurrent Nasopharynx Carcinoma
Intervention
Etoposide phosphate
Why stopped
This is a rare disease, and enrollment was poor.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-24